Position in VSTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,483,282
-$6,424,703 QoQ
Shares Held
650,074
-61.3% QoQ
Ownership
0.718%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#30
of 158 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VSTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. VSTM ranks #19 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in VSTM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,483,282 | 650,074 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,907,985 | 1,680,752 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,313,179 | 947,303 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,654,489 | 413,872 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,186,253 | 2,454,519 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,068,739 | 177,237 | Shares | Sole | 2025-05-15 | |
| 2021-06-30 | $219,779 | 54,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,424,115 | 576,565 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||